However, the expression of the hyperactive isoform IRAK4-L is also detected in MDS with SF3B1 mutation or without an underlying splicing factor mutation, hence the common implication of enhanced innate immune activation in MDS pathogenesis [68,69]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.